• Back To Listing

AllscriptsMisys $150m Stock Repurchase Program

STATEMENT RE: ALLSCRIPTSMISYS $150m STOCK REPURCHASE PROGRAMME
AND INCREASE IN CREDIT FACILITY COMMITMENTS

Misys plc (FTSE: MSY.L) notes that the Board of Directors of Allscripts-Misys Healthcare Solutions, Inc. (AllscriptsMisys) (NASDAQ: MDRX) has approved a stock repurchase programme under which AllscriptsMisys may purchase up to $150 million of its common stock over the next two years. AllscriptsMisys also announced an increase in credit facility commitments.

Misys plc owns 56.7% of AllscriptsMisys. Misys will participate in the repurchase programme with AllscriptsMisys. Misys will sell to AllscriptsMisys the number of shares of AllscriptsMisys needed to keep Misys’ ownership percentage unaffected by the open market repurchase. Repurchases of Misys’ stock will be made at the weighted average price at which repurchases are made by AllscriptsMisys under the open market plan. All repurchases under the programme are subject to compliance with applicable laws and regulations. Repurchases may be made pursuant to Rule 10b5-1 or 10b-18 of the US Securities Exchange Act of 1934, as amended.

The aggregate amount of shares purchased pursuant to the repurchase plan, whether pursuant to any 10b5-1 plan, Rule 10b-18 or from Misys, will not exceed the lesser of $150 million (including commissions) or 15 million shares. There is no guarantee as to the exact number of shares or value thereof that will be repurchased under the stock repurchase program, and AllscriptsMisys may discontinue purchases at any time. Any proceeds from the programme will be used by Misys to reduce indebtedness over time.

AllscriptsMisys also announced that it has entered into an amendment and restatement of its credit facility (the “credit facility”) of which JPMorgan Chase Bank, N.A. is agent, which increases commitments under the facility by $50 million to $125 million and adds Fifth Third Bank as syndication agent and co-lead arranger. The Credit Facility also may be expanded by an additional $25 million to $150 million. The initial interest rate on the Credit Facility is expected to be LIBOR plus 2.0%.

For additional detail on the changes to the AllscriptsMisys Credit Facility, please refer to the full agreement, which will be filed by AllscriptsMisys with the US Securities and Exchange Commission on a Form 8-K.

ENDS